CBS and cancer: Such studies may include silencing/knockout approaches (e.g., siRNA, shRNA or CRISPR) for CBS or 3-MST, with the caveat that these approaches may induce significant cytotoxicity due to the long-term absence of enzymes that may be crucial for cancer cell survival.